Dealing with the foreign‐body response to implanted biomaterials: strategies and applications of new materials
D Zhang, Q Chen, C Shi, M Chen, K Ma… - Advanced Functional …, 2021 - Wiley Online Library
Foreign‐body response caused by implanted biomaterials seriously impedes the function of
implants and is a major obstacle to the development of implantable biomaterials and …
implants and is a major obstacle to the development of implantable biomaterials and …
[HTML][HTML] Role of Phosphodiesterase in the Biology and Pathology of Diabetes
A Kilanowska, A Ziółkowska - International journal of molecular sciences, 2020 - mdpi.com
Glucose metabolism is the initiator of a large number of molecular secretory processes in β
cells. Cyclic nucleotides as a second messenger are the main physiological regulators of …
cells. Cyclic nucleotides as a second messenger are the main physiological regulators of …
Tetrahedral framework nucleic acids induce immune tolerance and prevent the onset of type 1 diabetes
S Gao, Y Li, D Xiao, M Zhou, X Cai, Y Lin - Nano letters, 2021 - ACS Publications
A failure in immune tolerance leads to autoimmune destruction of insulin-producing β-cells,
leading to type 1 diabetes (T1D). Inhibiting autoreactive T cells and inducing regulatory T …
leading to type 1 diabetes (T1D). Inhibiting autoreactive T cells and inducing regulatory T …
Targeting β cells with cathelicidin nanomedicines improves insulin function and pancreas regeneration in type 1 diabetic rats
C Cristelo, R Nunes, S Pinto, JM Marques… - ACS Pharmacology & …, 2023 - ACS Publications
Type 1 diabetes (T1D) is an incurable condition with an increasing incidence worldwide, in
which the hallmark is the autoimmune destruction of pancreatic insulin-producing β cells …
which the hallmark is the autoimmune destruction of pancreatic insulin-producing β cells …
Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetes
Pancreatic islet cells, and in particular insulin-producing beta cells, are centrally involved in
the pathogenesis of diabetes mellitus. These cells are of paramount importance for the …
the pathogenesis of diabetes mellitus. These cells are of paramount importance for the …
Cu‐Catalyzed Chan–Evans–Lam Coupling Reactions of 2‐Nitroimidazole with Aryl Boronic Acids: An Effort toward New Bioactive Agents against S. pneumoniae
S Raju, PE Sheridan, AK Hauer… - Chemistry & …, 2022 - Wiley Online Library
The coupling of phenylboronic acids with poorly‐activated imidazoles is studied as a model
system to explore the use of copper‐catalyzed Chan–Evans–Lam (CEL) coupling for …
system to explore the use of copper‐catalyzed Chan–Evans–Lam (CEL) coupling for …
[HTML][HTML] Current advances in using tolerogenic dendritic cells as a therapeutic alternative in the treatment of type 1 diabetes
W de Jesús Ríos-Ríos, SA Sosa-Luis… - World journal of …, 2021 - ncbi.nlm.nih.gov
Abstract Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction
of insulin-producing β-cells of the pancreatic islets by autoreactive T cells, leading to high …
of insulin-producing β-cells of the pancreatic islets by autoreactive T cells, leading to high …
[HTML][HTML] Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet regeneration
N Cobo-Vuilleumier, BR Gauthier - Metabolism, 2020 - Elsevier
Type 1 diabetes mellitus (T1DM) is an autoimmune disease that targets the destruction of
islet beta-cells resulting in insulin deficiency, hyperglycemia and death if untreated. Despite …
islet beta-cells resulting in insulin deficiency, hyperglycemia and death if untreated. Despite …
Diabetes type 1: can it be treated as an autoimmune disorder?
NG Vallianou, T Stratigou, E Geladari… - Reviews in Endocrine …, 2021 - Springer
Abstract Type 1 Diabetes Mellitus (T1DM) is characterized by progressive autoimmune-
mediated destruction of the pancreatic beta-cells leading to insulin deficiency and …
mediated destruction of the pancreatic beta-cells leading to insulin deficiency and …
[HTML][HTML] The Challenges to Advancing Induced Pluripotent Stem Cell-Dependent Cell Replacement Therapy
AB Moy, A Kamath, S Ternes… - Medical research archives, 2023 - ncbi.nlm.nih.gov
Induced pluripotent stem cells (iPSC) represent a potentially exciting regenerative-medicine
cell therapy for several chronic conditions such as macular degeneration, soft tissue and …
cell therapy for several chronic conditions such as macular degeneration, soft tissue and …